Investment Banking News Archives | Bailey Southwell & Co.

Bailey Southwell & Co. Advises Sedgwick in a Divestiture to ExamWorks

We are proud to announce we served as exclusive financial advisor to Sedgwick, a portfolio company of The Carlyle Group, in connection with its divestiture of its group health peer review (“GHPR”) and independent medical examination (“IME”) assets to ExamWorks, a...

Bailey Southwell & Co. Advises Tellus in its Sale to Netsmart

BSC News, Featured, Press Release

We are proud to announce we served as exclusive financial advisor to Tellus in connection with its sale to Netsmart Technologies, a portfolio company of TA Associates. Tellus offers a leading electronic visit verification and claims processing platform to states,...

Q&A with our new Managing Partner and Head of BSC Capital Partners Tim Scallen

Blog, BSC News, BSCCP Blog, Featured

We recently welcomed Tim Scallen to the BSC team as managing partner, leading BSC Capital Partners to build our direct investing capability and expand on our momentum in investing in differentiated middle-market companies. With a focus on payer, provider, and tech...

Tim Scallen Joins Bailey Southwell & Co. as Managing Partner to Lead BSC Capital Partners

BSC News, BSCCP News, BSCCP Press Release, Featured

We are pleased to announce the addition of Tim Scallen as Managing Partner to lead BSC Capital Partners (“BSCCP”), our affiliated principal investment fund that makes minority investments in growth and late-stage healthcare and tech-enabled services companies. Tim has...

Bailey Southwell 2019 Year in Review

BSC News, Featured

As we kick off the new year, we are thankful for the many great partnerships and connections we have made in 2019. We have compiled some of the top highlights, a review of our more than ten closed transactions, and a look into some of the most notable BSC internal...

Bailey Southwell Announces 2020 Promotions

BSC News, Press Release

We are proud to announce the promotions of four team members: Steven Harris, Ben Bates, Richard Jacques, and Chris Dougherty “Given our growth trajectory in healthcare M&A, we continue to make deep investments in our team and are excited to announce four key...